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Case Report
Dermatofibrosarcoma Protuberans: an unusual case of neck swelling
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Abstract
Dermatofibrosarcoma protuberans (DFSP) is a
relatively intermediate to low grade malignant tumour with
high proclivity for local recurrence if excised inadequately.
It is a locally aggressive tumour and despite sharing some
histological features with fibrohistiocytic tumours, it tends
to grow in a more infiltrative manner. We are reporting this
rare tumour in a 30-year-old woman where the diagnosis of
DFSP was confirmed histologically and by positive
immunomarkers at immunohistochemistry.
Keywords: Dermatofibrosarcoma protuberans, Recurrence,
Radiotherapy.

Introduction
Dermatofibrobrosarcoma protuberans (DFSP) is a
slow growing soft tissue neoplasm with intermediate to low
grade malignancy.1 It originates in the dermis, with a
tendency to invade the surrounding tissue. This infrequent
tumour typically presents as a solitary or a multilobulated,
slowly growing, and a painless cutaneous mass with
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possible elusive features.2 There is less clinical awareness
because of its relatively rare occurrence, and diagnosis is
made on histology. The surface is characterized by irregular
protruded multiple swelling, and a hard indurated plaque. It
is commonly diagnosed in young and middle aged adults,
but can involve children and elderly as well. Males are
affected four times as often as females.3 Trunk, proximal
extremities, head and neck regions are most commonly
involved.4 Surgical excision with wide margins is the main
stay of treatment. The DFSP has high tendency of
recurrence, due to its infiltrative asymmetric growth pattern.
Although metastasis is rarely seen but usually preceded by
multiple local recurrences. Surgery followed by postoperative radiotherapy may effectively reduce the local
recurrence rate.2

Case Report
A 30-year old female presented with right sided neck
swelling for 10 months duration with progressive increase
in size for the last two months. The swelling was localized
at the level of anterior surface of lower part of
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detected on examination of head and neck, systematic
examination was un-remarkable.
CT scan revealed a heterogeneously enhancing
lesion anterior to right sternocleidomastoid muscle (SCM),
involving skin and subcutaneous tissue without significant
lymphadenopathy (Figure-2).
Fine needle aspiration cytology (FNAC) showed
spindle cell neoplastic lesion, decision for wide local
excision was taken. Intra-operatively right SCM was found
to be firmly adherent to the tumour, sparing the strap
muscles. The tumour was excised with safe margins along
with overlying skin and involved part of SCM. Frozen
sections were sent, turned out to be negative.
Histopathologic studies showed uniform population of
spindle cells arranged in storiform pattern and exhibiting
pleomorphism with increase mitotic activity. These spindle
cells also showed infiltraltion into the muscle at the
periphery and perivascular lymphocytic infiltrate.
Immunohistochemical studies showed tumour cells positive
for Vimentin and CD34.
The patient was then referred to radiation oncology
services, and was treated with 68 Gy in 35 fractions. Post
radiotherapy she developed symptoms of hypothyroidism
for which oral thyroxine was started as a replacement. She
is on regular follow up for past 2 years and has presented no
evidence of local recurrence.
Figure-1: Photograph of neck showing multiple nodular swellings at lower neck.

Discussion
DFSP comprises roughly 0.01% of all malignant
tumours and approximately 2 to 6 percent of all soft tissue
sarcomas.4 The DFSP usually has a long slow indolent
course, with early tumours appearing as painless areas of
cutaneous thickening. They may have pink, dark red or even
bluish discoloration, particularly at its periphery. Over a
period of time, they develop into a larger nodular mass, and
ultimately can develop into a large fungating lesion. When
they grow into the epidermal layer of the skin, they may
eventually ulcerate. Unlike tumours of the subcutaneous
tissue, DSPF is adherent or intimate with its overlying skin.
Typically it is not adherent to underlying structures, with
most tumours being superficial and less than 5cm in size at
time of diagnosis.5

Figure-2: CT scan neck, axial cut, demonstrating heterogenous lesion anterior to
sternocleidomastoid muscle involving skin.

sternocleidomastoid muscle (Figure-1). The lesion was
about 4x3 cm painless, non-discharging, with erythematous
overlying skin. There was no reported significant family
history or history of addictions. No other abnormality was
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Typical presentation is in early or middle adult life
with a slow growing soft nodular cutaneous mass on the
trunk, although any part of the body may be involved. Given
the indolent growth and long preclinical duration, it has
been proposed likely that many of these tumours appearing
in young adulthood, actually begin during childhood.
Genetic analysis has shown that virtually all cases of DFSP
have a translocation that involves chromosomes 17 and 22,
resulting in fusion of the collagen 1 alpha 1 gene and
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platelet derived growth factor B genes.6
The DFSP has a characteristic histologic appearance
of uniform spindle cells arranged in a storiform or
"herringbone" pattern. Early lesions may demonstrate a
"Grenz zone," which is a tumour-free region separating the
tumour from the epidermis. Unusual variants of DFSP
include the Bednar tumour that is denoted by melanincontaining cell, myxoid DFSP that contains areas of
interstitial
mucin,
and
the
atrophic
type.
Immunohistochemical analysis can be utilized to aid in the
diagnosis. Staining for Vimentin and CD34 is commonly
employed, and sensitivity has been reported as being
between 84 and 100 percent.7
Surgery is the mainstay of treatment and wide
excision with a safety margin equal or more than 2 cm is
recommended with an emphasis on clear margin for local
recurrence.8 Although it is a time consuming technique,
Mohs micrographic surgery has been advocated by many
professionals as a favourable resection option.9
The use of radiotherapy in the treatment of DFSP has
been investigated in many studies.10 It is particularly
encouraged if resection is inadequate. Currently, there is
limited objective data to support its routine use; however,
successful application and recommendations have been
reported in very few small series.11
Imatinib mesylate was designed to treat Philadelphia
chromosome positive leukemia (chronic myelogenous
leukemia). The application of imatinib for DFSP has been
limited and its precise role in DFSP is currently under
investigation in many clinical trials.12
In conclusion, DFSP is a rare tumour and clinicians
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must suspect it if there is a painless, cutaneous and
multilobulated lesion. It can usually be well managed with
wide local excision as a single modality or if indicated
combined with radiotherapy.
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